UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Neurology, ISSN 0028-3878, 10/2012, Volume 79, Issue 15, pp. 1556 - 1562
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Frontotemporal Lobar Degeneration - pathology | Promoter Regions, Genetic | Genetic Predisposition to Disease | Sequestosome-1 Protein | Amyotrophic Lateral Sclerosis - genetics | Humans | Middle Aged | Male | Mutation, Missense | Amyotrophic Lateral Sclerosis - pathology | Adaptor Proteins, Signal Transducing - genetics | Aged, 80 and over | Brain - pathology | Female | Aged | Frontotemporal Lobar Degeneration - genetics | Index Medicus | Abridged Index Medicus | 178 | 29
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 07/2018, Volume 78, Issue 13, pp. 3731 - 3739
Life Sciences & Biomedicine | Oncology | Science & Technology | Genetic Predisposition to Disease | Humans | Middle Aged | Risk Factors | Computational Biology | Male | Incidence | tau Proteins - genetics | Neoplasms - genetics | Protein Interaction Maps - genetics | Pedigree | Female | Retrospective Studies | Frontotemporal Lobar Degeneration - genetics | Mutation | Genomic Instability - genetics | Neoplasms - epidemiology | Chromatin | Animal models | Recombination | Stability | Neurodegenerative diseases | Health risks | Genomes | Risk factors | Genomic instability | Proteins | Tau protein | Neurodegeneration | Degeneration | Mathematical models | Frontotemporal dementia | Bioinformatics | Cancer | mutation | epidemiology | bioinformatics | neurodegeneration | tau | cancer | MAPT | risk factor
Journal Article
Movement disorders, ISSN 0885-3185, 12/2019, Volume 34, Issue 12, pp. 1919 - 1924
cerebellar cognitive‐affective syndrome | founder effect | genealogical method | ATN1 gene | dentatorubral‐pallidoluysian atrophy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Genetic research | Medicine, Experimental | Medical research | Nervous system diseases | Genetic aspects | Atrophy | Neurodegenerative diseases | Pedigree | Epilepsy | Movement disorders | Cognitive ability | Index Medicus
Journal Article
Clinical interventions in aging, ISSN 1176-9092, 09/2015, Volume 10, pp. 1421 - 1429
Sirtuins | Neuroprotective effects | Citicoline | Neurodegeneration | Elderly | Cognitive impairment | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Cytidine Diphosphate Choline - pharmacology | Cognition Disorders - drug therapy | Humans | Nootropic Agents - pharmacology | Complications and side effects | Care and treatment | Research | Cytidine diphosphate choline | Health aspects | Alzheimer's disease | Studies | Membranes | Stroke | Traumatic brain injury | Ischemia | Memory | Cognitive ability | Biosynthesis | Metabolism | Alzheimers disease | Fatty acids | Animal cognition | Index Medicus | neurodegeneration | cognitive impairment | citicoline | elderly | neuroprotection
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 2018, Volume 61, Issue 1, pp. 251 - 257
Delirium | retrospective studies | prevalence | dementia | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Drugs | Neuroleptics | Demography | Mental disorders | Cognitive ability | Impairment | Medical records | Data processing | Population studies | Pharmacology | Family medical history | Patients | Cholinesterase inhibitors | Subgroups | Cholinesterase | Demographics | Memantine | Older people | Dementia disorders | Population | Geriatrics | Dementia | Index Medicus
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 2017, Volume 55, Issue 3, pp. 1249 - 1259
neurodegeneration | Niemann Pick type C | heterozygous state | NPC2 gene | Dementia | NPC1 gene | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dementia - diagnostic imaging | Glycoproteins - genetics | Brain - diagnostic imaging | Dementia - pathology | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | Dementia - genetics | Mutation - genetics | Membrane Glycoproteins - genetics | Carrier Proteins - genetics | Magnetic Resonance Imaging | Animals | DNA Mutational Analysis | Female | Aged | Niemann-Pick disease | Phenotypes | Disease | Splicing | Neurodegenerative diseases | Genes | mRNA | Patients | Genetic screening | Mimicry | Hereditary diseases | Diseases | Neurological diseases | Etiology | Progressive supranuclear palsy | Dementia disorders | Npc1 protein | Adults | Mutation | Paralysis | Index Medicus
Journal Article
Journal of neurology, ISSN 0340-5354, 12/2016, Volume 263, Issue 12, pp. 2494 - 2498
Neurology | Neurosciences | Medicine & Public Health | Alzheimer’s disease | Presenilin 1 | History of neurology | Genetic | Neuroradiology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - history | History, 21st Century | History, 20th Century | Humans | Presenilin-1 - genetics | Family Health | Female | History, 19th Century | Italy | Male | Alzheimer Disease - genetics | Mutation - genetics | Physiological aspects | Care and treatment | Genetic aspects | Diagnosis | Gene mutations | Alzheimer's disease | Index Medicus
Journal Article
Rivista di psichiatria, ISSN 0035-6484, 07/2019, Volume 54, Issue 4, pp. 137 - 149
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Trazodone - therapeutic use | Antidepressive Agents, Second-Generation - adverse effects | Trazodone - adverse effects | Humans | Sexual Dysfunction, Physiological - drug therapy | Bulimia - drug therapy | Trazodone - metabolism | Antidepressive Agents, Second-Generation - pharmacology | Anxiety - drug therapy | Antidepressive Agents, Second-Generation - therapeutic use | Randomized Controlled Trials as Topic | Neurocognitive Disorders - drug therapy | Drug Interactions | Trazodone - pharmacology | Stress Disorders, Post-Traumatic - drug therapy | Fibromyalgia - drug therapy | Substance-Related Disorders - drug therapy | Antidepressive Agents, Second-Generation - metabolism | Sleep Initiation and Maintenance Disorders - drug therapy | Delayed-Action Preparations | Depressive Disorder, Major - drug therapy
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P1234 - P1234
Journal Article
Neurobiology of aging, ISSN 0197-4580, 08/2017, Volume 56, pp. 213.e7 - 213.e12
Cerebellum | Presenilin 1 mutation | Spastic paraparesis | Alzheimer's disease | M84V | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Neuroimaging | Humans | Middle Aged | Cerebral Cortex - pathology | Male | Paraparesis, Spastic - genetics | Alzheimer Disease - pathology | Atrophy | Cerebellum - diagnostic imaging | Psychotic Disorders - diagnostic imaging | Female | Executive Function | Alzheimer Disease - psychology | Genetic Predisposition to Disease - genetics | Genetic Association Studies | Presenilin-1 - genetics | Cerebral Cortex - diagnostic imaging | Syndrome | Cerebellum - pathology | Magnetic Resonance Imaging | Psychotic Disorders - genetics | Pedigree | Aged | Paraparesis, Spastic - diagnostic imaging | Alzheimer Disease - diagnostic imaging | Mutation | Alzheimer Disease - genetics | Genes, Dominant - genetics | Brain | Genetic aspects | Codon | Index Medicus
Journal Article
Neurological sciences, ISSN 1590-1874, 9/2013, Volume 34, Issue 9, pp. 1581 - 1589
Neurology | Medicine & Public Health | Alzheimer’s disease | Drug treatment | Neurosurgery | Somatic comorbidities | Side effects/adverse events | Psychiatry | Elderly | Neuroradiology | Dementia | Alzheimer's disease | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Frail Elderly - statistics & numerical data | Comorbidity | Humans | Aged, 80 and over | Alzheimer Disease - drug therapy | Cholinesterase Inhibitors - adverse effects | Alzheimer Disease - epidemiology | Female | Male | Aged | Online health care information services | Drug therapy | Health aspects | Amyloid beta-protein | Index Medicus | Side effects | adverse events | Original
Journal Article